Odyssey Therapeutics expands the management team with key appointments in research and strategy development

Odyssey Therapeutics expands the management team with key appointments in research and strategy development

Jeff HermesKallyope, previously Roche, and Merck R&D lead, joins as Govt Vice President of Empowerment Sciences

Natalie OffersPh.D., promoted to Head of Analysis Operations and Portfolio Technique

BostonAnd the November 9, 2022 /PRNewswire/ — Odyssey Therapeutics, Inc. , a number one biotechnology firm within the subsequent era of micro-immune techniques and oncology medicine, introduced the appointment of Jeff HermesPh.D., as Govt Vice President of Empowerment and Promotion Sciences Natalie Offers, Ph.D., to the newly created place of Head of Analysis Operations and Portfolio Technique. In these roles, Dr. Hermes will oversee capability growth and implementation of Odyssey platform methodologies and applied sciences, and Dr. Delice will lead scientific technique and facilitate collaboration throughout the group.

“I’m delighted to welcome Jeff and Natalie to their new positions as I imagine they may contribute considerably to the corporate throughout this era of speedy development,” he mentioned. Gary de Glick, Ph.D., founder and CEO of Odyssey Therapeutics. “Jeff’s management in screening, pharmacology, and translational science, in addition to his experience throughout the drug discovery course of, can be invaluable as we proceed to create the following era of transformative medicine for sufferers with extreme autoimmune illnesses and tumors. Moreover, Natalie has performed an necessary position in serving to has helped form Odyssey’s analysis packages and technique throughout her time right here, and can proceed to advance our portfolio technique and streamline efforts throughout the corporate.”

Dr. Hermes can be answerable for creating the corporate’s proteomics, small molecule discovery platforms and transcription issue capabilities for subsequent era drug discovery. Dr. Dills will lead the scientific technique and decision-making for pipeline growth by way of scientific entry, creating connectivity and coherence between packages and capabilities, and overseeing the usage of assets to drive effectivity and synergies throughout the group.

Jeff HermesPh.D., Govt Vice President of Empowerment Sciences

Dr. Hermes is a seasoned professional with over 30 years of expertise in biochemistry, pharmacology and laboratory sciences within the biopharmaceutical trade. Most lately, Dr. Hermes served as Vice President of Laboratory Pharmacology at Kallyope, the place he led the efforts of in vitro pharmacology, screening and enzymes to create small-molecule transformative therapies that act on the gut-brain axis. Beforehand, he was the Head of Assay and Transformation Enzymes at Roche the place he was answerable for directing early stage efforts from discovery to growth candidate nomination. Previous to becoming a member of Roche, Dr. Hermes spent greater than 25 years at Merck and finally served as CEO and Head of the Screening and Protein Science Division, overseeing consequence analysis, management identification and translational science efforts in numerous therapeutic areas. He acquired his Ph.D. diploma in College of Wisconsin-Madison He accomplished his postdoctoral coaching at Harvard College.

Natalie OffersPh.D., Head of Analysis and Portfolio Technique

Dr. Dills has over 20 years of expertise main small molecule drug discovery in prescribed drugs and biotechnology. Dr. Dale most lately served as Govt Vice President of Empowerment Sciences at Odyssey. Beforehand, she spent greater than 15 years at Novartis, the place she held positions of elevated accountability together with CEO, Portfolio Head and Technique for International Discovery Chemistry. Previous to this position, she led small molecule drug discovery efforts targeted on liver, kidney, hematology, oncology, and uncommon illnesses. She was additionally a senior advisor at Novartis Genesis Labs, an in-house innovation incubator that promoted and funded disruptive ideas to speed up drug discovery.

About Odyssey Therapeutics

Odyssey Therapeutics is a biotechnology firm targeted on the invention, growth and commercialization of the following era of immunomodulators and oncology medicine. Comprised of an professional workforce of drug hunters, scientists, and trade leaders in foundational biology, chemistry and knowledge science, Odyssey is reworking drug discovery to speed up and drive the creation and environment friendly supply of life-enhancing precision medicine to sufferers. For extra info, please go to the web site http://www.odysseytx.com/ And observe Odyssey Therapeutics on Twitter (Tweet embed) And the LinkedIn.

Supply: Odyssey Therapeutics


#Odyssey #Therapeutics #expands #administration #workforce #key #appointments #analysis #technique #growth

Leave a Reply

Your email address will not be published.